跳至主要内容
临床试验/NCT02975050
NCT02975050已完成不适用

Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)

Kyma Medical Technologies0 个研究点目标入组 30 人开始时间: 2016年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
主要终点
Posture

研究概览

简要总结

This study has the following objective:

• To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects.

The μ-Cor validation will be demonstrated at two body locations:

  1. Side location (below left armpit) for study arm 1, and
  2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

详细描述

This study has the following objective:

• To validate the capability of the μ-Cor System to monitor ECG, Heart Rate (HR), Respiration Rate (RR), Posture and Activity in healthy human subjects.

The μ-Cor validation will be demonstrated at two body locations:

  1. Side location (below left armpit) for study arm 1, and
  2. Front location (upper left chest) for study arm 2 An FDA-cleared comparator device will be used to support the validation of the study device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is at least 21 years of age or older.
  • Subject is willing and able to sign the Informed Consent Form.
  • Subject is healthy, able and willing to complete all the preparation steps and study procedures.
  • Exclusion Criteria
  • Female subject with a known pregnancy or unsure about pregnancy status.
  • Subjects with allergies and/or skin sensitivities to electrode hydrogel and/or acrylic based adhesive.
  • Subjects with skin breakdown in areas where device placement is required.
  • Subjects with chronic lung disease or asthma.
  • Subjects with a history of cardiovascular diseases.
  • Subjects who are diabetic.
  • Subjects living with kidney failure or dialysis.
  • Subjects with a history of liver failure.
  • Subjects with any known malignancy (i.e. cancer patients).
  • Subjects with implanted devices in the thoracic region

排除标准

  • 未提供

结局指标

主要结局

Posture

时间窗: Immediately

90% agreement between the positions (supine / reclined / upright) derived from μCor reporting and the known position

Heart Rate

时间窗: Immediately

Respiratory rate

时间窗: Immediately

The difference between the μCor RR and the comparator RR will be lower than 2.8bpm (STD).

Activity

时间窗: Immediately

μCor output is provided as "active" and "not active". 90% correct classification of activity will be required of recordings.

ECG

时间窗: Immediately

次要结局

未报告次要终点

研究者

发起方
Kyma Medical Technologies
申办方类型
Industry
责任方
Sponsor

相似试验

Vital Signs Validation Study of the μ-Cor System... | 临床试验